MarketCap
Facebook
X
TelegramHancock Jaffe Laboratories, Inc. General and Administrative Expenses 2011-2026 | HJLI
General and Administrative Expenses — these are a part of a company's operating expenses that are not directly related to the production of goods or the provision of services but are necessary for the overall functioning of the business.What these expenses include
- Salaries of administrative staff (executives, HR, accountants, legal personnel)
- Office rent and utilities
- Office equipment and IT infrastructure
- Professional services (auditors, lawyers, consultants)
- Insurance
- General administrative travel and representation expenses
- Cost control
A high level of such expenses may indicate inefficient management or an overly complex structure - Profitability
Reducing administrative expenses while maintaining stable revenue increases operating profit - Comparative analysis
Investors can compare this metric as a percentage of revenue among companies in the same industry - Business flexibility
Companies with a flexible and controlled expense structure are more resilient to revenue declines
Annual General and Administrative Expenses Hancock Jaffe Laboratories, Inc.
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|
| 4.88 K | 4.91 M | 6.48 M | 5.46 M | 4.63 M | 1.29 M | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 6.48 M | 4.88 K | 3.8 M |
General and Administrative Expenses of other stocks in the Medical devices industry
| Issuer | General and Administrative Expenses | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Aziyo Biologics
AZYO
|
14.1 M | - | 1.37 % | $ 20.5 M |  USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
25.6 M | - | - | $ 1.77 B | USA |
 |
Conformis
CFMS
|
28.8 M | - | - | $ 16.4 M | USA |
 |
Bruker Corporation
BRKR
|
894 M | $ 39.27 | -1.36 % | $ 5.85 K | USA |
 |
Cardiovascular Systems
CSII
|
171 M | - | 0.15 % | $ 844 M | USA |
 |
Cutera
CUTR
|
63.3 M | - | -10.19 % | $ 1.99 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
8.78 M | - | -5.86 % | $ 30.6 M | USA |
 |
Acutus Medical
AFIB
|
14.1 M | - | -26.83 % | $ 2.62 M | USA |
 |
Dynatronics Corporation
DYNT
|
8.46 M | - | 14.99 % | $ 929 K | USA |
 |
Eargo
EAR
|
54.3 M | - | - | $ 10.2 M | USA |
 |
Cognyte Software Ltd.
CGNT
|
163 M | $ 7.82 | 4.13 % | $ 561 M |  Israel |
 |
Allied Healthcare Products
AHPI
|
7.11 M | - | 3.58 % | $ 2.21 M | USA |
 |
Second Sight Medical Products
EYES
|
806 K | - | -0.97 % | $ 54.4 M | USA |
 |
AdaptHealth Corp.
AHCO
|
382 M | $ 9.4 | -2.49 % | $ 1.27 B | USA |
 |
Apollo Endosurgery
APEN
|
20.6 M | - | - | $ 475 M | USA |
 |
EDAP TMS S.A.
EDAP
|
5.9 M | $ 3.99 | -2.68 % | $ 149 M |  France |
 |
CONMED Corporation
CNMD
|
132 M | $ 43.41 | -5.2 % | $ 1.35 B | USA |
 |
Electromed
ELMD
|
39.3 M | $ 23.98 | -0.5 % | $ 203 M | USA |
 |
CryoLife, Inc.
CRY
|
141 M | - | -4.14 % | $ 702 M | USA |
 |
Avinger
AVGR
|
14.1 M | - | -20.74 % | $ 369 K | USA |
 |
AxoGen
AXGN
|
44.6 M | $ 29.83 | -2.68 % | $ 1.37 B | USA |
 |
Apyx Medical Corporation
APYX
|
22.2 M | $ 3.17 | -3.35 % | $ 110 M | USA |
 |
Axonics Modulation Technologies
AXNX
|
40.2 M | - | - | $ 3.31 B | USA |
 |
FONAR Corporation
FONR
|
23.5 M | $ 18.5 | -0.32 % | $ 121 M | USA |
 |
Soliton, Inc.
SOLY
|
8.46 M | - | -1.42 % | $ 435 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
8.5 M | - | 0.03 % | $ 1.58 B | Israel |
 |
Accuray Incorporated
ARAY
|
47.9 M | $ 0.53 | -4.57 % | $ 54.5 M | USA |
 |
Misonix, Inc.
MSON
|
18 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
14.7 M | - | - | $ 111 M |  Canada |
 |
Medigus Ltd.
MDGS
|
9.96 M | - | 10.28 % | $ 55.5 M | Israel |
 |
Cytosorbents Corporation
CTSO
|
35 M | $ 0.8 | 6.81 % | $ 43.5 M | USA |
 |
Align Technology
ALGN
|
1.76 B | $ 182.64 | -3.38 % | $ 13.7 B | USA |
 |
Intersect ENT, Inc.
XENT
|
98.6 M | - | - | $ 955 M | USA |
 |
Inari Medical
NARI
|
293 M | - | - | $ 4.23 B | USA |
 |
Butterfly Network
BFLY
|
39.8 M | $ 3.68 | -4.42 % | $ 779 M | USA |
 |
BIOLASE
BIOL
|
10.2 M | - | -13.19 % | $ 166 K | USA |
 |
Abbott Laboratories
ABT
|
12.3 B | $ 113.61 | -0.45 % | $ 198 B | USA |
 |
NuVasive
NUVA
|
634 M | - | - | $ 2.07 B | USA |
 |
Nevro Corp.
NVRO
|
310 M | - | - | $ 217 M | USA |
 |
BioSig Technologies
BSGM
|
11.6 M | - | 37.08 % | $ 85.7 M | USA |
 |
Boston Scientific Corporation
BSX
|
6.89 B | $ 73.85 | -3.11 % | $ 109 B | USA |
 |
Helius Medical Technologies
HSDT
|
9.27 M | $ 1.98 | -6.6 % | $ 1.2 M | USA |
 |
Alphatec Holdings
ATEC
|
499 M | $ 13.02 | -3.34 % | $ 1.95 B | USA |
 |
InMode Ltd.
INMD
|
8.41 M | $ 13.6 | -0.29 % | $ 879 M | Israel |
 |
Edwards Lifesciences Corporation
EW
|
2.09 B | $ 85.28 | -2.18 % | $ 49.9 B | USA |
 |
IRIDEX Corporation
IRIX
|
8.75 M | $ 1.43 | 1.42 % | $ 23.1 M | USA |
 |
IRadimed Corporation
IRMD
|
15.9 M | $ 104.29 | 0.53 % | $ 1.32 B | USA |